Skip to main content
. 2024 Apr 29;30(6):1559–1563. doi: 10.1038/s41591-024-02939-2

Extended Data Fig. 3. Trust in science, health authorities, government and pharmaceutical industry.

Extended Data Fig. 3

Sample size for each individual country n = 1,000. Middle- Income Countries (MIC): Brazil, China, Ecuador, Ghana, India, Kenya, Mexico, Nigeria, Peru, Russia, South Africa, Turkiye. High-Income Countries (HIC): Canada, France, Germany, Italy, Poland, Singapore, South Korea, Spain, Sweden, United Kingdom, United States. Survey items: (a) ‘I trust the science behind the COVID-19 vaccines available to me,’ (b) ‘How much do you trust the health authorities that recommended you get a COVID-19 vaccine?,’ (c) ‘How much did you trust your government’s management of the COVID-19 pandemic in your country?,’ (d) ‘Did the development of COVID-19 vaccines affect your trust in science generally?,’ (e) ‘Did the development of the COVID-19 vaccines affect your trust in the pharmaceutical industry?’.